These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32699183)

  • 1. The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages.
    Yu Y; Xie K; Lou Q; Xia H; Wu D; Dai L; Hu C; Wang K; Shan S; Hu Y; Tang W
    Aging (Albany NY); 2020 Jul; 12(14):14066-14079. PubMed ID: 32699183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 3. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus.
    Cui R; Qi Z; Zhou L; Li Z; Li Q; Zhang J
    Clin Interv Aging; 2016; 11():445-52. PubMed ID: 27143868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between brachial-ankle pulse wave velocity and glycemic control of type 2 diabetes mellitus patients in Beijing community population].
    Sun KX; Liu ZK; Cao YY; Juan J; Xiang X; Yang C; Huang SP; Liu XF; Li N; Tang X; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):431-6. PubMed ID: 26080871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials.
    Rajagopalan R; Xu Y; Abbadessa M;
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):123-33. PubMed ID: 16860259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus].
    Cao YY; Tang X; Sun KX; Liu ZK; Xiang X; Juan J; Song J; Duan QZ; Zhaxi DJ; Hu YN; Yang YF; Shi MY; Tian YH; Huang SP; Liu XF; Li N; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):446-450. PubMed ID: 28628145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical characteristics of Chinese elderly patients with different durations of type 2 diabetes mellitus.
    Yu Y; Xie K; Lou Q; Xia H; Wu D; Dai L; Hu C; Shan S; Wang K; Tang W
    Front Endocrinol (Lausanne); 2022; 13():904347. PubMed ID: 35966087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of glucose-lowering rate on CKMB and myoglobin serum levels in type-2 diabetes patients with coronary heart disease.
    Sun Z; Wu W; Liu J; Ma N; Zheng Z; Li Q; Wang M; Miao J
    Hum Immunol; 2014 Dec; 75(12):1182-7. PubMed ID: 25454625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediating effect of BMI on the relation of dietary patterns and glycemic control inT2DM patients: results from China community-based cross-sectional study.
    Saiyi Wang ; Wen J; Miao D; Sun Z; Li D; Pan E
    BMC Public Health; 2023 Mar; 23(1):468. PubMed ID: 36899345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin.
    Kashi Z; Mahrooz A; Kianmehr A; Alizadeh A
    PLoS One; 2016; 11(3):e0151543. PubMed ID: 26978661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes--reference data from the German diabetes documentation and quality management system (DPV).
    Schwab KO; Doerfer J; Naeke A; Rohrer T; Wiemann D; Marg W; Hofer SE; Holl RW;
    Pediatr Diabetes; 2009 May; 10(3):184-92. PubMed ID: 19175904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
    Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.